We are monitoring the impact of COVID-19 on Autoimmune Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1125
Share on
Share on

Global Autoimmune Diagnostics Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Test Type, Disease Type, End-User & Region - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1125
Pages: 182

Autoimmune Diagnostics Market Size (2021 to 2026)

The global autoimmune diagnostics market size was worth USD 14.54 billion in 2021 and is forecasted to be worth USD 17.35 billion by the end of 2026. This market registers a CAGR of 3.6% during the forecast period.

Autoimmune disease is a disorder where the patient’s immune system attacks its body tissues, leading to body organs' damage. Nearly 80 types of autoimmune diseases are known so far.

MARKET DRIVERS:

The high incidences of autoimmune diseases and growing awareness about autoimmune diseases further contribute to the growth of the global autoimmune diagnostics market.

The global autoimmune diagnostics market is forecasted to have tremendous growth during the forecast period. It is receiving a significant boost from a rise in the prevalence of autoimmune disorders like people with type 1 diabetes in newborn babies with copulation of demand for rapid diagnostics.

Additionally, a rise in R & D on autoimmune diseases is predicted to favor the market's growth rate. Across the globe, many research and diagnostics industries are undertaking new initiatives with a complication with government organizations by owning a rise in the prevalence of autoimmune disorders. They will have a consequence on healthcare expenditure, as per the National Institutes of Health (NIH) data published that these disorders are in the top ranking, which leads to an increment in mortality rates among women. The factors mentioned above are the primary and significant drivers of the autoimmune diagnostics market.   

MARKET RESTRAINTS:

Some of the restraints factors, such as the high frequency of false-positive results and having an extended turnaround time for diagnostic test results, limit the market growth to a small extent. In addition, high expenditures, less awareness regarding various diseases, and diagnostic measures are other significant restraints. Moreover, fewer income companies and the rise of economy countries to address some issues for autoimmune diseases diagnostics market.

Impact of COVID-19 on the global autoimmune diagnostics market:

The novel coronavirus caused by the SARS-CoV-2reagent and has disrupted every sector worldwide. The medical industry has observed severe ups and downs during the pandemic crisis. In general, women with frequent autoimmune rheumatic diseases have a similar risk compared to men over the pandemic time. The pandemic has imposed some challenges for patients with immune involved with inflammatory autoimmune systemic disorders. One of the government's top issues from COVID-19 is the unbearable necessity of examining and testing many people for virus infection. Some infected patients may develop autoimmune situations like SLE, multiple sclerosis, and some autoinflammatory conditions in children. The autoimmune diagnostics market faces some challenges with a heavy burden in supplying efficient test kits and accelerating the medical industry's attention. There has been an expanding case of rheumatoid arthritis (RA) is registered post different viral outbreaks. As of May 13, 2020, 872 rheumatic patient cases were reported infected with coronavirus as per the COVID 19 Global Rheumatology Alliance. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Test Type, Disease Type & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli Lilly, and GlaxoSmithKline Plc.

 

This research report on the global autoimmune diagnostics market has been segmented and sub-segmented based on the test type, disease type, and region.

Autoimmune Diagnostics Market - By Test Type:

  • Autoantibody Tests
  • Antinuclear Antibody Tests
  • Complete Blood Count (CBC)
  • C-reactive protein (CRP) 
  • Comprehensive Metabolic panel  
  • Urinalysis 
  • Erythrocyte Sedimentation Rate (ESR)     
  • Others

The autoantibody tests segment is predicted to dominate the global market during the forecast period based on the test type. An autoantibody is the largest among all the elements of the autoimmune diagnostics market.

Autoimmune Diagnostics Market - By Disease Type:

  • Localized autoimmune disease diagnostics
    • Graves' Disease
    • Hashimoto's Thyroiditis
    • Multiple Sclerosis
    • Type 1 diabetes
    • Psoriasis
    • Others
  • Systemic autoimmune disease diagnostics
    • Rheumatoid Arthritis (RA)
    • Ankylosing Spondylitis
    • Systemic Lupus Erythematosus (SLE)

Based on the disease type, the localized autoimmune disease diagnostics segment was the market leader in 2020 and is predicted to witness healthy growth during the forecast period. The segment is majorly driven by the heavy procedural volumes and relevantly high compared to systemic autoimmune disease diagnostics. As per the American Autoimmune Related Diseases Association, approximately 50 million people are suffering from related autoimmune disorders.

The systematic autoimmune disease diagnostics market is expected to grow at the fastest CAGR during the forecast period. Due to the burgeoning prevalence of rheumatoid arthritis, the rheumatoid arthritis segment, surging consciousness of the disease, and government support, aid in market development. For example, Amgen exhibited a safety trial for diagnostics in treating Systematic Lupus Erythematous. 

Autoimmune Diagnostics Market - By End User:

  • Hospitals
  • Research Centers
  • Diagnostic Laboratories

Based on the end-user, the hospital end-user segment is projected to play a leading role in the global autoimmune diagnostics market growth. Hospitals use advanced technologies to organize multiple tests at the same time with robust and appropriate results. The surging autoimmune disease consultations

The research centers and diagnostic labs worldwide are likely to encourage measures in coordinating with the government sectors due to growing incidences of autoimmune disorders and expansion of investments in the healthcare field. These factors represent the segment's growth worldwide. In addition, many of the research and diagnostic centers commit to organizing public awareness activities in educating singles regarding autoimmune diseases and possible treatment options and diagnoses. The mentioned factors influence the segment positively.

Autoimmune Diagnostics Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American region is estimated to rule the global autoimmune diagnostics market during the forecast period with the highest share, followed by Europe, Asia Pacific. The Asia-pacific market is expected to account for the highest growth during the forecast period.

As anticipated, the North American region contributed to the highest revenue share above 39.2% in 2019. This North American region is owning factors such as the presence of favorable initiatives and regulations by AARDA. Moreover, the North American area is also having a high prevalence of diseases. 

During the forecast period, the Asia-Pacific region has a lucrative growth-share by owning many advantages such as improving healthcare infrastructure and the rapid growth of patients’ awareness levels. Moreover, the Asia-Pacific region is having a rise in an increment of revenue share. As a result, the expected revenue share of the autoimmune diagnostics market in the Asia-Pacific region has a CAGR of over 22.0%, from 19.5% in 2015 to 2025.

The European region is also accounting highest share due to the presence of UK country during the forecast period. Furthermore, the European region has advantageous factors such as increment of economic burden with copulation with increased research and developed activities further influencing the European region's growth. Additionally, the increment of demand for better and accurate diagnosis for systematic localized diseases positively impacts the autoimmune diagnostic market.

KEY MARKET PLAYERS:

Notable participants leading the global autoimmune diagnostics market profiled in the report are Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli Lilly and GlaxoSmithKline Plc.

RECENT MARKET HAPPENINGS:

  • In 2019, ZEUS IFA test systems were launched by Cambridge Life Sciences limited in the US country.
  • In 2019, US FDA EUROIMMUN Anti-Tissue Transglutaminase ELISA approval was received by PerkinElmer, Inc. It will help the confirmation of clinicians for celiac disease diagnosis.
  • In 2019, an agreement was made between Exagen Inc. with GSK earlier extended for a year. This extension will help the key players to drive awareness about challenges by facing lupus diagnosis and management.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Test Type                              

                                5.1.1 Autoantibody Tests             

                                5.1.2 Antinuclear Antibody Tests              

                                5.1.3 Complete Blood Count (CBC)          

                                5.1.4 C - reactive protein (CRP) 

                                5.1.5 Comprehensive Metabolic panel   

                                5.1.6 Urinalysis 

                                5.1.7 Erythrocyte Sedimentation Rate (ESR)        

                                5.1.8 Others      

                5.2 By Disease Type                       

                                5.2.1 Localized auto immune disease diagnostics              

                                                5.2.1.1 Graves' Disease

                                                5.2.1.2 Hashimoto's Thyroiditis

                                                5.2.1.3 Multiple Sclerosis

                                                5.2.1.4 Type 1 diabetes

                                                5.2.1.5 Psoriasis

                                                5.2.1.6 Others

                                5.2.2 Systemic auto immune disease diagnostics

                                                5.2.2.1 Rheumatoid Arthritis (RA)

                                                5.2.2.2 Ankylosing Spondylitis

                                                5.2.2.3 Systemic Lupus Erythematosus (SLE)

                5.3 By End Users                             

                                5.3.1 Hospitals  

                                "5.3.2 Research centers

 

"             

                                5.3.3 Diagnostic laboratories      

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Mexico     

                                6.4.4 Rest of Latin America         

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                        

                8.1 Bio-Rad                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Siemens Healthcare                

                8.3 Abbott Laboratories               

                8.4 Crescendo Bioscience                            

                8.5 Roche Diagnostics                    

                8.6 SQI Diagnostics                         

                8.7 AESKU Diagnostics                   

                8.8 INOVA Diagnostics                  

                8.9 BioMerieux SA                          

                8.10 Beckman Coulter Inc.                           

                8.11 Hemagen Diagnostics                          

                8.12 Quest Diagnostics                  

                8.13 Eli lilly                         

                8.14 Glaxosmithkline Plc                              

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Autoimmune diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  3. Global Autoantibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  4. Global Antinuclear Antibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  5. Global Complete Blood Count (CBC) Market, By Region, From 2021 to 2026 (USD Million)
  6. Global C - reactive protein (CRP) Market, By Region, From 2021 to 2026 (USD Million)
  7. Global Comprehensive Metabolic panel Market, By Region, From 2021 to 2026 (USD Million)
  8. Global Urinalysis Market, By Region, From 2021 to 2026 (USD Million)
  9. Global Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2021 to 2026 (USD Million)
  10. Global Other Test Types Market, By Region, From 2021 to 2026 (USD Million)
  11. Global Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  12. Global Localized Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  13. Global Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  14. Global Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  15. Global Graves' Disease Market, By Region, From 2021 to 2026 (USD Million)
  16. Global Hashimoto's Thyroiditis Market, By Region, From 2021 to 2026 (USD Million)
  17. Global Multiple Sclerosis Market, By Region, From 2021 to 2026 (USD Million)
  18. Global Type 1 diabetes Market, By Region, From 2021 to 2026 (USD Million)
  19. Global Psoriasis Market, By Region, From 2021 to 2026 (USD Million)
  20. Global Other Localized Autoimmune Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  21. Global Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  22. Global Rheumatoid Arthritis (RA) Market, By Region, From 2021 to 2026 (USD Million)
  23. Global Ankylosing Spondylitis Market, By Region, From 2021 to 2026 (USD Million)
  24. Global Systemic Lupus Erythematosus (SLE) Market, By Region, From 2021 to 2026 (USD Million)
  25. North America Autoimmune diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  26. North America Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  27. North America Autoantibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  28. North America Antinuclear Antibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  29. North America Complete Blood Count (CBC) Market, By Region, From 2021 to 2026 (USD Million)
  30. North America C - reactive protein (CRP) Market, By Region, From 2021 to 2026 (USD Million)
  31. North America Comprehensive Metabolic panel Market, By Region, From 2021 to 2026 (USD Million)
  32. North America Urinalysis Market, By Region, From 2021 to 2026 (USD Million)
  33. North America Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2021 to 2026 (USD Million)
  34. North America Other Test Types Market, By Region, From 2021 to 2026 (USD Million)
  35. North America Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  36. North America Localized Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  37. North America Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  38. United States Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  39. United States Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  40. Canada Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  41. Canada Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  42. North America Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  43. North America Graves' Disease Market, By Region, From 2021 to 2026 (USD Million)
  44. North America Hashimoto's Thyroiditis Market, By Region, From 2021 to 2026 (USD Million)
  45. North America Multiple Sclerosis Market, By Region, From 2021 to 2026 (USD Million)
  46. North America Type 1 diabetes Market, By Region, From 2021 to 2026 (USD Million)
  47. North America Psoriasis Market, By Region, From 2021 to 2026 (USD Million)
  48. North America Other Localized Autoimmune Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  49. United States Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  50. Canada Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  51. North America Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  52. North America Rheumatoid Arthritis (RA) Market, By Region, From 2021 to 2026 (USD Million)
  53. North America Ankylosing Spondylitis Market, By Region, From 2021 to 2026 (USD Million)
  54. North America Systemic Lupus Erythematosus (SLE) Market, By Region, From 2021 to 2026 (USD Million)
  55. United States Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  56. Canada Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  57. Europe Autoimmune diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  58. Europe Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  59. Europe Autoantibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  60. Europe Antinuclear Antibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  61. Europe Complete Blood Count (CBC) Market, By Region, From 2021 to 2026 (USD Million)
  62. Europe C - reactive protein (CRP) Market, By Region, From 2021 to 2026 (USD Million)
  63. Europe Comprehensive Metabolic panel Market, By Region, From 2021 to 2026 (USD Million)
  64. Europe Urinalysis Market, By Region, From 2021 to 2026 (USD Million)
  65. Europe Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2021 to 2026 (USD Million)
  66. Europe Other Test Types Market, By Region, From 2021 to 2026 (USD Million)
  67. Europe Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  68. Europe Localized Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  69. Europe Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  70. U.K Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  71. U.K Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  72. Spain Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  73. Spain Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  74. Germany Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  75. Germany Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  76. Italy Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  77. Italy Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  78. France Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  79. France Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  80. Europe Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  81. Europe Graves' Disease Market, By Region, From 2021 to 2026 (USD Million)
  82. Europe Hashimoto's Thyroiditis Market, By Region, From 2021 to 2026 (USD Million)
  83. Europe Multiple Sclerosis Market, By Region, From 2021 to 2026 (USD Million)
  84. Europe Type 1 diabetes Market, By Region, From 2021 to 2026 (USD Million)
  85. Europe Psoriasis Market, By Region, From 2021 to 2026 (USD Million)
  86. Europe Other Localized Autoimmune Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  87. U.K Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  88. Spain Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  89. Germany Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  90. Italy Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  91. France Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  92. Europe Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  93. Europe Rheumatoid Arthritis (RA) Market, By Region, From 2021 to 2026 (USD Million)
  94. Europe Ankylosing Spondylitis Market, By Region, From 2021 to 2026 (USD Million)
  95. Europe Systemic Lupus Erythematosus (SLE) Market, By Region, From 2021 to 2026 (USD Million)
  96. U.K Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  97. Spain Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  98. Germany Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  99. Italy Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  100. France Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  101. Asia-Pacific Autoimmune diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  102. Asia-Pacific Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  103. Asia-Pacific Autoantibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  104. Asia-Pacific Antinuclear Antibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  105. Asia-Pacific Complete Blood Count (CBC) Market, By Region, From 2021 to 2026 (USD Million)
  106. Asia-Pacific C - reactive protein (CRP) Market, By Region, From 2021 to 2026 (USD Million)
  107. Asia-Pacific Comprehensive Metabolic panel Market, By Region, From 2021 to 2026 (USD Million)
  108. Asia-Pacific Urinalysis Market, By Region, From 2021 to 2026 (USD Million)
  109. Asia-Pacific Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2021 to 2026 (USD Million)
  110. Asia-Pacific Other Test Types Market, By Region, From 2021 to 2026 (USD Million)
  111. Asia-Pacific Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  112. Asia-Pacific Localized Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  113. Asia-Pacific Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  114. China Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  115. China Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  116. India Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  117. India Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  118. Japan Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  119. Japan Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  120. South Korea Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  121. South Korea Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  122. Australia Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  123. Australia Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  124. Asia-Pacific Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  125. Asia-Pacific Graves' Disease Market, By Region, From 2021 to 2026 (USD Million)
  126. Asia-Pacific Hashimoto's Thyroiditis Market, By Region, From 2021 to 2026 (USD Million)
  127. Asia-Pacific Multiple Sclerosis Market, By Region, From 2021 to 2026 (USD Million)
  128. Asia-Pacific Type 1 diabetes Market, By Region, From 2021 to 2026 (USD Million)
  129. Asia-Pacific Psoriasis Market, By Region, From 2021 to 2026 (USD Million)
  130. Asia-Pacific Other Localized Autoimmune Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  131. China Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  132. India Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  133. Japan Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  134. South Korea Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  135. Australia Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  136. Asia-Pacific Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  137. Asia-Pacific Rheumatoid Arthritis (RA) Market, By Region, From 2021 to 2026 (USD Million)
  138. Asia-Pacific Ankylosing Spondylitis Market, By Region, From 2021 to 2026 (USD Million)
  139. Asia-Pacific Systemic Lupus Erythematosus (SLE) Market, By Region, From 2021 to 2026 (USD Million)
  140. China Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  141. India Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  142. Japan Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  143. South Korea Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  144. Australia Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  145. Latin America Autoimmune diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  146. Latin America Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  147. Latin America Autoantibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  148. Latin America Antinuclear Antibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  149. Latin America Complete Blood Count (CBC) Market, By Region, From 2021 to 2026 (USD Million)
  150. Latin America C - reactive protein (CRP) Market, By Region, From 2021 to 2026 (USD Million)
  151. Latin America Comprehensive Metabolic panel Market, By Region, From 2021 to 2026 (USD Million)
  152. Latin America Urinalysis Market, By Region, From 2021 to 2026 (USD Million)
  153. Latin America Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2021 to 2026 (USD Million)
  154. Latin America Other Test Types Market, By Region, From 2021 to 2026 (USD Million)
  155. Latin America Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  156. Latin America Localized Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  157. Latin America Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  158. Brazil Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  159. Brazil Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  160. Argentina Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  161. Argentina Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  162. Mexico Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  163. Mexico Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  164. Latin America Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  165. Latin America Graves' Disease Market, By Region, From 2021 to 2026 (USD Million)
  166. Latin America Hashimoto's Thyroiditis Market, By Region, From 2021 to 2026 (USD Million)
  167. Latin America Multiple Sclerosis Market, By Region, From 2021 to 2026 (USD Million)
  168. Latin America Type 1 diabetes Market, By Region, From 2021 to 2026 (USD Million)
  169. Latin America Psoriasis Market, By Region, From 2021 to 2026 (USD Million)
  170. Latin America Other Localized Autoimmune Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  171. Brazil Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  172. Argentina Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  173. Mexico Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  174. Latin America Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  175. Latin America Rheumatoid Arthritis (RA) Market, By Region, From 2021 to 2026 (USD Million)
  176. Latin America Ankylosing Spondylitis Market, By Region, From 2021 to 2026 (USD Million)
  177. Latin America Systemic Lupus Erythematosus (SLE) Market, By Region, From 2021 to 2026 (USD Million)
  178. Brazil Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  179. Argentina Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  180. Mexico Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  181. Middle East & Africa Autoimmune diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  182. Middle East & Africa Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  183. Middle East & Africa Autoantibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  184. Middle East & Africa Antinuclear Antibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  185. Middle East & Africa Complete Blood Count (CBC) Market, By Region, From 2021 to 2026 (USD Million)
  186. Middle East & Africa C - reactive protein (CRP) Market, By Region, From 2021 to 2026 (USD Million)
  187. Middle East & Africa Comprehensive Metabolic panel Market, By Region, From 2021 to 2026 (USD Million)
  188. Middle East & Africa Urinalysis Market, By Region, From 2021 to 2026 (USD Million)
  189. Middle East & Africa Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2021 to 2026 (USD Million)
  190. Middle East & Africa Other Test Types Market, By Region, From 2021 to 2026 (USD Million)
  191. Middle East & Africa Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  192. Middle East & Africa Localized Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  193. Middle East & Africa Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  194. Middle East Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  195. Middle East Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  196. Africa Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  197. Africa Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  198. Middle East & Africa Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  199. Middle East & Africa Graves' Disease Market, By Region, From 2021 to 2026 (USD Million)
  200. Middle East & Africa Hashimoto's Thyroiditis Market, By Region, From 2021 to 2026 (USD Million)
  201. Middle East & Africa Multiple Sclerosis Market, By Region, From 2021 to 2026 (USD Million)
  202. Middle East & Africa Type 1 diabetes Market, By Region, From 2021 to 2026 (USD Million)
  203. Middle East & Africa Psoriasis Market, By Region, From 2021 to 2026 (USD Million)
  204. Middle East & Africa Other Localized Autoimmune Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  205. Middle East Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  206. Africa Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  207. Middle East & Africa Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  208. Middle East & Africa Rheumatoid Arthritis (RA) Market, By Region, From 2021 to 2026 (USD Million)
  209. Middle East & Africa Ankylosing Spondylitis Market, By Region, From 2021 to 2026 (USD Million)
  210. Middle East & Africa Systemic Lupus Erythematosus (SLE) Market, By Region, From 2021 to 2026 (USD Million)
  211. Middle East Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  212. Africa Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample